Skip to content

All best practices

BP-041Grade B61 supporting cases (59 counted), 0 counter-examples

Treat regulators and the state as design constraints from day one, with priced remedies and a fallback

The practice

Map every regulator's and the state's likely concerns early, design products and deals to pass review, price remedies and conditions into the plan, and keep a fallback for any move that needs approval.

Why it works

Regulatory approval, foreign-investment clearance, competition law and licensing can block or reshape a transformation, and in several KB cases a move that needed approval was blocked or delayed (Philips Lumileds, Siemens-Alstom, Air New Zealand-Qantas, Boeing-Embraer). Designing a deal or product to pass review, engaging regulators and unions early, and pricing remedies as a workstream turns approval risk into a managed constraint. A plan that depends on a deal the regulator controls needs a fallback. For new products such as mobile money, engaging the regulator early and accepting limits in exchange for permission can make the market possible. Competition constraints tighten as share grows, so the design must change with it.

KB synthesis: the mechanism is the knowledgebase's own reasoning, drawn from the member lessons. Factual support is the case claims under evidence.cases and the research under evidence.research (R-refs).

How to apply it

  • List every regulator and state body with a say, and their likely concerns, at the option stage.
  • Engage regulators and unions before announcement; design the deal or product to meet their tests.
  • Price expected remedies and disposals into the deal and run them as a workstream.
  • Define a fallback for every portfolio move or plan element that needs approval.
  • Get the licence each product actually needs, market by market, and revisit competition exposure as share grows.

Warning signs

  • Approval is assumed in the base case with no fallback.
  • Only the home regulator has been consulted.
  • Product launches outrun licensing.

When it applies

  • Mergers, divestments, cross-border deals, fintech and telecom products, and strategically sensitive sectors.

When it does not

  • Unregulated activities with no competition or state-ownership dimension.

Evidence grade: Grade B

At least 6 counted supporting cases for every 100 cases in the knowledgebase (6 × cases ÷ 100, rounded to the nearest whole number), whose primary regions span at least 4 regions.

Why this grade

Grade B by schema 4.10 route: >=14 counted cases across >=4 primary regions (the case bar is 6 per 100 cases in the knowledgebase, 235 cases). A needs a systematic, peer-reviewed study that tests this practice. None of the research cited in the KB does. 2 supporting case(s) rest only on company-reported claims and are not counted toward the grade.

Where it applies

Transformation type
  • T10 Market entry and expansion
Topic (business problem)
  • Cyber and technology risks threaten continuity
  • Supply chain disruption has made the network fragile
  • Service delivery is too slow, unreliable or expensive
  • Regulatory complexity is overwhelming controls
  • Energy, resource or climate exposure undermines economics
  • Forecasts are unreliable in a volatile environment
Function
  • Operations & Service Delivery
  • Risk, Compliance & Internal Audit
Starting situation
  • New initiative
  • In-flight initiative
  • Completed (review)
Industry
  • B2B SaaS and Subscription Software
  • Chemicals and Process Manufacturing
  • Commercial Banking
  • Commercial Real Estate and REITs
  • Discrete Manufacturing
  • Electric Power Utilities
  • Food and Beverage Manufacturing
  • Grocery and Food Retail
  • Hospitals and Health Systems
  • Hotels, Lodging and Hospitality
  • Logistics, Warehousing and 3PL
  • Other (cross-industry)
  • Professional Services: Accounting, Law and Advisory
  • Telecommunications, Broadband and Fiber
Region
  • Africa
  • Central and Eastern Europe
  • East Asia
  • Global
  • Latin America
  • Middle East
  • North America
  • Oceania
  • South Asia
  • Southeast Asia
  • Western Europe

Supporting and counter cases

Researched and fact-checked knowledgebase · Knowledgebase built 5 November 2026

Practices, their evidence grades and case summaries are public. Full case studies are available in AXIOM to subscribers and AXIOM Discover participants.